Anoctamin 6 Regulates C2C12 Myoblast Proliferation
Author(s) -
Piming Zhao,
Audrey Torcaso,
Andrew Mariano,
Li Xu,
Sadia Mohsin,
Lixia Zhao,
Renzhi Han
Publication year - 2014
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0092749
Subject(s) - c2c12 , microbiology and biotechnology , myocyte , protein kinase b , skeletal muscle , biology , pi3k/akt/mtor pathway , mapk/erk pathway , cell growth , phosphorylation , signal transduction , myogenesis , chemistry , endocrinology , biochemistry
Anoctamin 6 ( Ano6 ) belongs to a conserved gene family (TMEM16) predicted to code for eight transmembrane proteins with putative Ca 2+ -activated chloride channel (CaCC) activity. Recent work revealed that disruption of ANO6 leads to a blood coagulation defect and impaired skeletal development. However, its function in skeletal muscle cells remains to be determined. By using a RNA interference mediated (RNAi) loss-of-function approach, we show that Ano6 regulates C2C12 myoblast proliferation. Ano6 is highly expressed in C2C12 myoblasts and its expression decreases upon differentiation. Knocking down Ano6 significantly reduces C2C12 myoblast proliferation but has minimal effect on differentiation. Ano6 deficiency significantly reduces ERK/AKT phosphorylation, which has been shown to be involved in regulation of cancer cell proliferation by another Anoctamin member. Taken together, our data demonstrate for the first time that Ano6 plays an essential role in C2C12 myoblast proliferation, likely via regulating the ERK/AKT signaling pathway.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom